Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Airway; Obstruction, With Emphysema”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT00970268
What this trial is testing

Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 291
Large-scale testing (Phase 3)Study completedNCT01572792
What this trial is testing

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 921
Testing effectiveness (Phase 2)Study completedNCT00683722
What this trial is testing

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaChronic Bronchitis
Mesoblast, Inc. 62
Not applicableLooking for participantsNCT07152834
What this trial is testing

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

Who this might be right for
Alpha 1-antitrypsin Deficiency (AATD)
Muğla Sıtkı Koçman University 734
Post-approval studies (Phase 4)WithdrawnNCT01903850
What this trial is testing

TruFreeze™ Airway Obstruction: TAO STUDY

Who this might be right for
Lung Disease AirwaysLung Diseases, ObstructiveAirway; Obstruction, With Emphysema+1 more
CSA Medical, Inc.
Testing effectiveness (Phase 2)Study completedNCT01551888
What this trial is testing

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 24
Testing effectiveness (Phase 2)Study completedNCT01049360
What this trial is testing

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 128
Testing effectiveness (Phase 2)UnknownNCT06003270
What this trial is testing

Biological Effects of Quercetin in COPD Phase II

Who this might be right for
Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis With Airway Obstruction
Temple University 30
Not applicableActive Not RecruitingNCT03049202
What this trial is testing

BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study

Who this might be right for
Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis+3 more
Karolinska Institutet 1,000
Large-scale testing (Phase 3)Study completedNCT01045161
What this trial is testing

Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 544
Large-scale testing (Phase 3)Study completedNCT01437397
What this trial is testing

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,692
Large-scale testing (Phase 3)Study completedNCT01437540
What this trial is testing

Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 590
Not applicableStudy completedNCT03657121
What this trial is testing

Mortality and Symptom Burden Post Hospitalisation With COPD

Who this might be right for
Pulmonary Disease, Chronic ObstructivePulmonary Disease, ObstructiveEmphysema+3 more
Northumbria Healthcare NHS Foundation Trust 447
Large-scale testing (Phase 3)Study completedNCT01044459
What this trial is testing

Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 605
Large-scale testing (Phase 3)Study completedNCT00891462
What this trial is testing

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 561
Not applicableStudy completedNCT01013948
What this trial is testing

Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,574